|
2002.
Avanti Therapeutics (AT-GC) is founded. Financed with
$100,000, Biotechnology executives with more than 100 years of combined
experience, started a biopharmaceutical company to develop personalized
medicines for infectious diseases and cancer
October, 2002...
AT-GC uses its personalized
medicine platform to initiate a comprehensive disease management solution for
Hepatitis B.
2002...
Avanti Therapeutics collaborates
with Scientists from Harvard Medical School-Gene Therapy Program to
commercialize their oncology product portfolio.
Back to Our History...
|
|
2003..
AT-GC Collaborates with Scientists from
Jefferson Hospital and Hepatitis B Foundation to develop Nucleic acid based
vaccines for hepatitis B and C.
2003..
AT-GC BioPharm
Files Provisional Patent Applications on Signature Manufacturing for
Biopharmaceuticals
2003...
AT-GC BioPharm signs an agreement
with largest Indian Biotech company to provide expertise to develop and
commercialize products for infectious diseases and cancer.
|
|
2004
AT-GC signs a contract to work with
GeoCenters and CBTEK Inc. to develop a sensor to detect bioterror agents.
AT-GC
commercializes technology licensed from US Depatment of Defense.
2004
AT-GC initiates a program on Nanotechnology for life sciences.
2004
AT-GC iBioPharm starts collaboration with Nucleonics Inc. for process
development.
2004
AT-GC initiates a process development agreement with PhotoChem Laboratories,
India
|
|
March, 2005...
Omnia Biologics, AT-GC BioPharm form strategic manufacturing
alliance
April, 2005...
After a year of development
AT-GC initiates a nanotechnology based process analytics platform. The
analytical tools helps biopharma companies with improved quality productivity and yields.
April, 2005...
CBTEK LLC And ATGC BioPharm
Enter Into A Process Development Agreement For Biodefense
April, 2005...
ATGC BioPharm and Omnia
Biologics to Collaborate on Manufacturing of Novel Therapeutic
Biopharmaceuticals
July, 2005...
AT-GC BioPharm wins a
process development contract from TissueGene
August, 2005...
AT-GC Analytics introduces comprehensive Endotoxin Management Platform
for Biopharma Industry.
|
|
